225 related articles for article (PubMed ID: 29666038)
1. Correlation of Serum CCL3/MIP-1α Levels with Disease Severity in Postmenopausal Osteoporotic Females.
Wan H; Qian TY; Hu XJ; Huang CY; Yao WF
Balkan Med J; 2018 Jul; 35(4):320-325. PubMed ID: 29666038
[TBL] [Abstract][Full Text] [Related]
2. Serum CX3CL1/fractalkine concentrations are positively associated with disease severity in postmenopausal osteoporotic patients.
Chen YD; Huang CY; Liu HY; Yao WF; Wu WG; Lu YL; Wang W
Br J Biomed Sci; 2016 Jul; 73(3):121-128. PubMed ID: 27476376
[TBL] [Abstract][Full Text] [Related]
3. Elevated CCL2/MCP-1 Levels are Related to Disease Severity in Postmenopausal Osteoporotic Patients.
Yang XW; Wang XS; Cheng FB; Wang F; Wan L; Wang F; Huang HX
Clin Lab; 2016 Nov; 62(11):2173-2181. PubMed ID: 28164676
[TBL] [Abstract][Full Text] [Related]
4. Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis.
Mederle OA; Balas M; Ioanoviciu SD; Gurban CV; Tudor A; Borza C
Clin Interv Aging; 2018; 13():1383-1389. PubMed ID: 30122910
[TBL] [Abstract][Full Text] [Related]
5. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women.
Fodor D; Bondor C; Albu A; Simon SP; Craciun A; Muntean L
J Investig Med; 2013 Jan; 61(1):15-21. PubMed ID: 23117696
[TBL] [Abstract][Full Text] [Related]
6. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population.
Han W; Bai X; Wang N; Han L; Sun X; Chen X
Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105
[TBL] [Abstract][Full Text] [Related]
7. The Neuropeptide Vasoactive Intestinal Peptide Levels in Serum are Inversely Related to Disease Severity of Postmenopausal Osteoporosis: A Cross-Sectional Study.
Wang W; Wang ZP; Huang CY; Chen YD; Yao WF; Shi BM
Genet Test Mol Biomarkers; 2019 Jul; 23(7):480-486. PubMed ID: 31157986
[No Abstract] [Full Text] [Related]
8. Elevated serum CCL4/MIP-1β levels in postmenopausal osteoporosis patients are linked with disease severity.
Yang XW; Wang F; Qin RZ; Zhou QL; Huang HX
Biomark Med; 2019 Jan; 13(1):17-25. PubMed ID: 30561228
[TBL] [Abstract][Full Text] [Related]
9. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
[TBL] [Abstract][Full Text] [Related]
10. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
11. Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women.
Wei QS; Huang L; Tan X; Chen ZQ; Chen SM; Deng WM
Scand J Clin Lab Invest; 2016; 76(1):33-9. PubMed ID: 26414945
[TBL] [Abstract][Full Text] [Related]
12. Relationship between body composition and age, menopause and its effects on bone mineral density at segmental regions in Central Southern Chinese postmenopausal elderly women with and without osteoporosis.
Liu S; Li J; Sheng Z; Wu X; Liao E
Arch Gerontol Geriatr; 2011; 53(2):e192-7. PubMed ID: 20880598
[TBL] [Abstract][Full Text] [Related]
13. Serum chitotriosidase in postmenopausal women with severe osteoporosis.
Musumeci M; Palermo A; D'Onofrio L; Vadalà G; Greto V; Di Stasio E; Maddaloni E; Di Rosa M; Tibullo D; Angeletti S; Napoli N; Denaro V; Manfrini S
Osteoporos Int; 2016 Feb; 27(2):711-6. PubMed ID: 26243359
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.
Qin YJ; Zhang ZL; Zhang H; Hu WW; Liu YJ; Hu YQ; Li M; Gu JM; He JW
Acta Pharmacol Sin; 2008 Dec; 29(12):1493-8. PubMed ID: 19026169
[TBL] [Abstract][Full Text] [Related]
15. Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women.
Liu SZ; Tian LF; Xu P; Zhuang GH; Zheng F; Tian J; Ning QL; Zhu BF; Lu SM; Yan H
Mol Biol Rep; 2011 Feb; 38(2):939-48. PubMed ID: 20490690
[TBL] [Abstract][Full Text] [Related]
16. Serum C-C Motif Ligand 11/eotaxin-1 May Serve as a Candidate Biomarker for Postmenopausal Osteoporosis.
Wang W; Huang CY; Wang ZP; Xu SS; Qian TY; Chen YD; Wu WG
J Med Biochem; 2019 Jul; 38(3):353-360. PubMed ID: 31156346
[TBL] [Abstract][Full Text] [Related]
17. Serum tumour necrosis factor alpha in osteopenic and osteoporotic postmenopausal females: A cross-sectional study in Pakistan.
Murad R; Shezad Z; Ahmed S; Ashraf M; Qadir M; Rehman R
J Pak Med Assoc; 2018 Mar; 68(3):428-431. PubMed ID: 29540879
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification.
Grampp S; Genant HK; Mathur A; Lang P; Jergas M; Takada M; Glüer CC; Lu Y; Chavez M
J Bone Miner Res; 1997 May; 12(5):697-711. PubMed ID: 9144335
[TBL] [Abstract][Full Text] [Related]
19. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
20. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
